PharmaResearch
Financials
Valuation Metrics
PharmaResearch's Market Cap is ₩4.0T. At end of 2025 it was ₩4.2T. Ranked #118 of 2,436 in KR market (top 5%), #12 of 1,649 on KOSDAQ (top 0.7%), #11 of 234 in Pharmaceuticals, Biotechnology & Life Sciences (top 5%) by Market Cap.
Investment Metrics(as of 2026-08-04)
| Metric | Value | Rank |
|---|---|---|
| Size | ||
| Market Cap | 3.99T KRW | KR#118/2,436 Sec#11/234 |
| Revenue | 565.48B KRW | KR#569/2,436 Sec#27/234 |
| Net Income | 180.98B KRW | KR#141/2,436 Sec#8/234 |
| Total Assets | 1.09T KRW | KR#448/2,436 Sec#25/234 |
| Net Assets | 732.48B KRW | KR#358/2,436 Sec#24/234 |
| Employees | 436 | KR#561/2,436 Sec#45/234 |
| Value | ||
| P/E | 22.07x | KR#1,144/2,436 Sec#67/234 |
| P/B | 5.45x | KR#2,254/2,436 Sec#188/234 |
| PEG | 0.63x | KR#699/2,436 Sec#42/234 |
| P/S | 7.06x | KR#2,213/2,436 Sec#150/234 |
| EV/EBITDA | 16.73x | KR#916/2,436 Sec#53/234 |
| FCF Yield | 3.84% | KR#944/2,436 Sec#54/234 |
| Profitability | ||
| ROE | 24.71% | KR#80/2,436 Sec#6/234 |
| ROA | 16.67% | KR#58/2,436 Sec#6/234 |
| Op. Margin | 40.13% | KR#24/2,436 Sec#6/234 |
| Revenue Growth | 24.97% | KR#552/2,436 Sec#54/234 |
| Earnings Growth | 35.31% | KR#653/2,436 Sec#40/234 |
| Financial Health | ||
| Debt Ratio | 148.18% | KR#1,163/2,436 Sec#133/234 |
| Total Debt | 6.25B KRW | KR#1,738/2,436 Sec#163/234 |
| FCF | 153.44B KRW | KR#134/2,436 Sec#5/234 |
| Cash | 204.37B KRW | KR#265/2,436 Sec#10/234 |
| Current Ratio | 5.69x | KR#242/2,436 Sec#49/234 |
| Net Debt/EBITDA | -0.87x | KR#489/2,436 Sec#26/234 |
| Dividend | ||
| Div. Yield | 1.00% | KR#1,142/2,436 Sec#68/234 |
| Div. Growth | 236.36% | KR#37/2,436 Sec#1/234 |
| Performance | ||
| 1Y Return | -30.72% | KR#1,589/2,436 Sec#137/234 |
| 1M Return | 12.76% | KR#214/2,436 Sec#13/234 |
| From 52W High | -46.07% | KR#1,020/2,436 Sec#81/234 |
| 1Y MDD | -63.57% | KR#1,619/2,436 Sec#132/234 |
| Trading | ||
| Volume | 172,659 shares | KR#645/2,436 Sec#62/234 |
| Foreign Own. | 7.29% | KR—/2,436 Sec—/234 |
| Per Share | ||
| EPS | 15,228 KRW | KR#45/2,436 Sec#4/234 |
| BPS | 60,258 KRW | KR#204/2,436 Sec#12/234 |
Company Info
PharmaResearch was founded in 2001 as a pharmaceutical and medical device development and consulting company, later establishing a GMP-certified factory in 2013 and completing its second factory in 2019. As a biopharmaceutical company, it researches, manufactures, and sells pharmaceuticals, medical devices, and cosmetics for various medical fields, including dermatology and orthopedics. Leveraging its technological competitiveness, the company is committed to R&D and market expansion, pursuing global business by entering Asian, European, and North American markets. PharmaResearch was established in 2001 and is headquartered in Gangneung-si, Gangwon-do.